Laboratory Corporation of America Holdings Annual Shareholders Meeting Transcript
Good morning. I'm Adam Schechter, President and Chief Executive Officer and Chairman of the Board of LabCorp. I'm happy to welcome you to the Annual Meeting of Shareholders.
Before we get started, I want to thank our mission-driven colleagues around the world. We dedicated significant resources to important clinical areas, including oncology, NASH, autoimmune disease and women's health. We quickly brought innovations to market, and we advanced each pillar of our company strategy, which led us to deliver robust financial performance. We continue to demonstrate remarkable leadership in a fight against COVID-19, leveraging LabCorp's comprehensive capabilities to expand testing access to identify and monitor new variants and to advanced vaccine and therapy development.
We are delivering vital information to help our customers and patients make clear and confident decisions that improve health and improve lives. The meeting will now come to order. All votes will be delivered to the Inspector of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |